Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 11, 2019
Patent Application Number
15941783
Date Filed
March 30, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided are compounds that are inhibitors of both rho kinase and of a monoamine transporter (MAT) act to improve the disease state or condition. Further provided are compositions comprising the compounds. Further provided are methods for treating diseases or conditions, the methods comprising administering compounds according to the invention. One such disease may be glaucoma for which, among other beneficial effects, a marked reduction in intraocular pressure (IOP) may be achieved.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
